Key facts
- Notable investors include Shenzhen Capital Group, Qianhai FoF.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Ruijianhuitong
- ·The full record, as it builds
Funding rounds
No funding rounds for Ruijianhuitong are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ruijianhuitong
Developer and provider of innovative ophthalmic drugs designed for the treatment of eye diseases. The company focuses on research and development (R&D), providing healthcare professionals with effective therapeutic solutions.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Founded
- 2025
- Ownership
- Privately Held (backing)
Ruijianhuitong doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ruijianhuitong shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ruijianhuitong in its N-PORT filings yet. We sweep new filings monthly.